What is the treatment of Shanghai Dongfulong Technology Co., Ltd.?

The treatment of Shanghai Dongfulong Technology Co., Ltd. is quite good. The basic salary of fresh graduates during the probation period is 3,000-3,500 yuan/month, and the living allowance in 500 yuan. After signing the contract, the annual salary is 45,000-70,000 (after tax). According to the gradual improvement of ability, employees will be assessed once every quarter, and the annual basic salary will increase by 8%-65,438+00%.

Social elites (those with more than two years relevant work experience or junior titles) have a probation period of 6,000-8,000 yuan/month, and the annual salary after signing the contract is 8- 1.2 million yuan (after tax).

The company's main products cover the top 100 domestic pharmaceutical companies and 565,438+0 well-known foreign pharmaceutical companies. Typical customers include leading biomedical enterprises such as Harbin Pharmaceutical Group, Younuokang, Shanghai Pharmaceutical Group, Yang Zijiang Pharmaceutical Group, China Biomedical Group and its six biological research institutes, as well as veterinary medicine representative enterprises such as Melia Animal Health Co., Ltd., China Animal Husbandry Co., Ltd. and Harbin Veterinary Medicine Research Institute.

It also includes Intas Pharmaceuticals Ltd, Strides Arcolab Ltd, Aurobindo Pharma Ltd and other world-renowned pharmaceutical companies.